VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromeLast Updated:March 18, 2016Completed